11-Dec-2025
Targeting collagen signaling boosts drug delivery in pancreatic cancer
Okayama UniversityPeer-Reviewed Publication
Researchers from Okayama University and Tohoku University have discovered that targeting collagen signaling through the discoidin domain receptor 1 (DDR1) enhances drug delivery and reverses therapy-induced resistance in pancreatic cancer. Their study shows that DDR1 inhibition improves macromolecular drug penetration and mitigates fibrosis triggered by MEK inhibitors, offering new hope for more effective treatment strategies.
- Journal
- Small
- Funder
- Japan Society for the Promotion of Science (KAKENHI), Japan Science and Technology Agency (JST), COI-NEXT Program, Okayama University, Harmonic Ito Foundation, Inamori Foundation, Hokuto Foundation for Bioscience, Research Foundation for Pharmaceutical Sciences, Japan Foundation for Applied Enzymology, Pancreas Research Foundation of Japan, Sanyo Broadcasting Foundation Ryobi Teien Memory Foundation, KAWASAKI Foundation for Medical Science and Medical Welfare